295788-93-1Relevant articles and documents
Total synthesis of the novel benzophenone NP-011694
Noncovich, Alain,Ung, Jane,Patron, Andrew
, p. 4836 - 4839 (2015)
We report the total synthesis of NP-011694, a previously unreported fungal fermentation product from Analyticon Gmbh. The convergent synthesis employs Turbo Grignard and lithiation strategies, along with novel conditions for the simultaneous removal of mu
NOVEL 4-(HETEROCYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND ALSO IN COSMETICS
-
Page/Page column 15-16, (2010/06/20)
The present invention relates to novel 4- (heterocycloalkyl) benzene- 1,3-diol compounds corresponding to general formula (I) below: to the compositions containing same, to the process for the preparation thereof and to the use thereof in pharmaceutical or cosmetic compositions for use in the treatment or prevention of pigmentary disorders
Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 2: Structure-activity relationship studies on the benzopyran scaffold
Richardson, Timothy I.,Norman, Bryan H.,Lugar, Charles W.,Jones, Scott A.,Wang, Yong,Durbin, Jim D.,Krishnan, Venkatesh,Dodge, Jeffrey A.
, p. 3570 - 3574 (2008/02/04)
Benzopyrans are selective estrogen receptor (ER) β agonists (SERBAs), which bind the ER subtypes α and β in opposite orientations. Here we describe structure-activity relationship studies that led to the discovery of bezopyran 5b. X-ray crystal structures